Výsledky vyhledávání - "Malatestinic W"

Akademický článek

Real-World Treatment Patterns, Clinical Outcomes, and Symptom Burden in Patients With Psoriatic Arthritis Prescribed Ixekizumab in the United States.

Autor: Rohekar S; Western University, London, Ontario, Canada., Vadhariya A; Eli Lilly and Company, Indianapolis, Indiana., Ross S; Eli Lilly and Company, Indianapolis, Indiana., Malatestinic W; Eli Lilly and Company, Indianapolis, Indiana., Janos B; Eli Lilly and Company, Indianapolis, Indiana., Massey N; Adelphi Real World, Bollington, United Kingdom., Hughes M; Adelphi Real World, Bollington, United Kingdom., Weatherby S; Adelphi Real World, Bollington, United Kingdom., Birt J; Eli Lilly and Company, Indianapolis, Indiana., Sebba A; University of South Florida, Tampa, Florida.

Publikováno v: ACR open rheumatology [ACR Open Rheumatol] 2024 Jul; Vol. 6 (7), pp. 440-449. Date of Electronic Publication: 2024 May 05.

Zobrazit plný text záznamu

Editorial & Opinion

Letter to the Editor: Response to Fitzgerald T et al. Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA.

Autor: Blauvelt A; Oregon Medical Research Center, Portland, OR, USA. ablauvelt@oregonmedicalresearch.com., Garrelts A; Eli Lilly and Company, Indianapolis, IN, USA., Malatestinic W; Eli Lilly and Company, Indianapolis, IN, USA., Birt J; Eli Lilly and Company, Indianapolis, IN, USA., Zhu B; Eli Lilly and Company, Indianapolis, IN, USA., Feely M; Eli Lilly and Company, Indianapolis, IN, USA.

Publikováno v: Dermatology and therapy [Dermatol Ther (Heidelb)] 2023 Nov; Vol. 13 (11), pp. 2911-2916. Date of Electronic Publication: 2023 Sep 26.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Assessment of the benefit of achieving complete versus almost complete skin clearance in psoriasis: a patient's perspective.

Autor: Korman NJ; University Hospitals Case Medical Center, Cleveland, OH, USA., Malatestinic W; Lilly USA, LLC, Indianapolis, IN, USA., Goldblum OM; Lilly USA, LLC, Indianapolis, IN, USA., Murage MJ; Lilly USA, LLC, Indianapolis, IN, USA., Renda L; Lilly USA, LLC, Indianapolis, IN, USA., Lin CY; Lilly USA, LLC, Indianapolis, IN, USA., Lucas J; Adelphi Real World, Bollington, UK., Middleton C; Adelphi Real World, Bollington, UK., Lobosco S; Adelphi Real World, Bollington, UK.

Publikováno v: The Journal of dermatological treatment [J Dermatolog Treat] 2022 Mar; Vol. 33 (2), pp. 733-739. Date of Electronic Publication: 2020 Jun 01.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

A Retrospective Cohort Analysis of Treatment Patterns Over 1 Year in Patients with Psoriasis Treated with Ixekizumab or Guselkumab.

Autor: Blauvelt A; Oregon Medical Research Center, 9495 SW Locust St., Suite G, Portland, OR, 97223, USA. ablauvelt@oregonmedicalresearch.com., Burge R; Eli Lilly and Company, Indianapolis, IN, USA.; University of Cincinnati, Cincinnati, OH, USA., Gallo G; Eli Lilly and Company, Indianapolis, IN, USA., Charbonneau B; Eli Lilly and Company, Indianapolis, IN, USA., Malatestinic W; Eli Lilly and Company, Indianapolis, IN, USA., Zhu B; Eli Lilly and Company, Indianapolis, IN, USA., Wan F; Eli Lilly and Company, Indianapolis, IN, USA., Lockshin B; DermAssociates, Silver Spring, MD, USA.

Publikováno v: Dermatology and therapy [Dermatol Ther (Heidelb)] 2022 Mar; Vol. 12 (3), pp. 701-714. Date of Electronic Publication: 2022 Feb 26.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

401 Using electronic health records to evaluate factors associated with treatment escalation in psoriasis

Autor: Rhoads, J.L., Malatestinic, W., Burge, R., Ganz, M.L., Saravanan, S., Duffin, K.C.

Publikováno v: In Journal of Investigative Dermatology May 2021 141(5) Supplement:S70-S70

Zobrazit plný text záznamu

Akademický článek

Real-World Treatment Patterns and Healthcare Costs in Patients with Psoriatic Arthritis Treated with Ixekizumab: A Retrospective Study.

Autor: Murage MJ; Eli Lilly and Company, Indianapolis, Indiana., Princic N; IBM Watson Health, Cambridge, Massachusetts., Park J; IBM Watson Health, Cambridge, Massachusetts., Malatestinic W; Eli Lilly and Company, Indianapolis, Indiana., Zhu B; Eli Lilly and Company, Indianapolis, Indiana., Atiya B; Eli Lilly and Company, Indianapolis, Indiana., Kern SA; Eli Lilly and Company, Indianapolis, Indiana., Stenger KB; Eli Lilly and Company, Indianapolis, Indiana., Sprabery AT; Eli Lilly and Company, Indianapolis, Indiana., Ogdie A; Hospital of the University of Pennsylvania, Philadelphia.

Publikováno v: ACR open rheumatology [ACR Open Rheumatol] 2021 Dec; Vol. 3 (12), pp. 879-887. Date of Electronic Publication: 2021 Sep 22.

Zobrazit plný text záznamu

Akademický článek

Impact of psoriasis disease severity and special area involvement on patient-reported outcomes in the real world: an analysis from the CorEvitas psoriasis registry.

Autor: Strober, Bruce¹ brucestrober30@me.com, Duffin, Kristina Callis², Lebwohl, Mark³, Sima, Adam⁴, Janak, Jud⁴, Patel, Manish⁵, Photowala, Huzefa⁵, Garg, Vishvas⁵, Bagel, Jerry⁶

Publikováno v: Journal of Dermatological Treatment. Dec2024, Vol. 35 Issue 1, p1-8. 8p.

Zobrazit plný text záznamu

Akademický článek

Cost per cumulative clinical benefit of biologic therapies for patients with plaque psoriasis: a systematic review.

Autor: Blauvelt A; Oregon Medical Research Center, Portland, OR., Burge R; Eli Lilly and Company, Indianapolis, IN, and University of Cincinnati, Cincinnati, OH., Malatestinic W; Eli Lilly and Company, Indianapolis, IN., Brnabic A; Eli Lilly and Company, Indianapolis, IN., Guo J; Eli Lilly and Company, Indianapolis, IN., Janardhanan M; Eli Lilly Services India Pvt. Ltd., Bangalore, India., Zhu B; Eli Lilly and Company, Indianapolis, IN.

Publikováno v: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2021 Jan; Vol. 27 (1), pp. 84-94.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání